VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
72,296
AK1,638
AL5,339
AR3,412
AS44
AZ13,316
CA58,147
CO11,002
CT7,824
DC1,626
DE1,670
FL36,235
FM3
GA13,429
GU82
HI2,195
IA4,332
ID2,473
IL19,261
IN22,568
KS4,284
KY6,945
LA4,714
MA13,886
MD11,901
ME2,997
MH8
MI17,865
MN11,345
MO8,919
MP30
MS2,676
MT2,147
NC15,401
ND1,273
NE2,732
NH2,859
NJ17,232
NM3,702
NV4,071
NY32,763
OH18,072
OK5,940
OR7,954
PA22,457
PR2,104
QM2
RI1,911
SC6,055
SD1,133
TN8,691
TX34,122
UT4,023
VA13,944
VI49
VT1,661
WA13,811
WI10,395
WV2,220
WY805
XB5
XL1
XV2

ID: 1542524
Sex: F
Age: 51
State: NJ

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itchiness of tongue; Itchiness of throat; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TONGUE PRURITUS (Itchiness of tongue) and THROAT IRRITATION (Itchiness of throat) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma (Medical history reported as asthma), Allergy to nuts (Medical history reported as allergies to peanuts), Allergy NOS (Medical history reported as allergies) and Migraine NOS (Medical history reported as migraines). On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 15-Jan-2021, the patient experienced TONGUE PRURITUS (Itchiness of tongue) and THROAT IRRITATION (Itchiness of throat). At the time of the report, TONGUE PRURITUS (Itchiness of tongue) and THROAT IRRITATION (Itchiness of throat) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment for the events Benadryl and Zyrtec. No relevant concomitant medications were reported by the reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness: Allergy NOS (Medical history reported as allergies); Allergy to nuts (Medical history reported as allergies to peanuts); Asthma (Medical history reported as asthma); Migraine NOS (Medical history reported as migraines)

ID: 1542525
Sex: F
Age: 40
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant; This spontaneous prospective pregnancy case was reported by a pharmacist and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. Concurrent medical conditions included Fruit allergy (Peach, plumps, cherrys, melon). Concomitant products included PROGESTERONE and ACETYLSALICYLIC ACID (ASPIRIN PROTEC) for Pregnancy, FOLIC ACID for an unknown indication. On 26-Jan-2021 at 11:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 03-Jun-2020 and the estimated date of delivery was 13-Mar-2021. On 26-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-third week of the pregnancy. On 26-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Jul-2020, Pregnancy test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. On ??-???-2020, lab test also included APT down diamniotic; however, the result was negative and RH positive. Patient had two prior pregnancies. Patient delivered first neonate on 22-Oct-2009, which resulted in live preterm birth of baby within the duration of 35 weeks with 6 days. Patient delivered second neonate on 18-Dec-2019, which resulted in live preterm birth of baby within the duration of 36 weeks with 6 days. Number of fetus was found to be one. Treatment information was not provided.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds: PROGESTERONE; ASPIRIN PROTEC; FOLIC ACID

Current Illness: Fruit allergy (Peach, plumps, cherrys, melon)

ID: 1542526
Sex: F
Age: 50
State: TX

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt just like when she had COVID; 104.8 fever; Chills; Bad headache; A lot of nausea; Just sore initially; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Just sore initially), VACCINATION COMPLICATION (Felt just like when she had COVID), PYREXIA (104.8 fever), CHILLS (Chills) and HEADACHE (Bad headache) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L(or C)20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 in October 2020, Colectomy, Ileostomy, Total gastrectomy and Hysterectomy. Concurrent medical conditions included Drug allergy (Morphine, codeine, hydrocodone, butran, dermabond, IV iron sucrose and iron dextran). Concomitant products included GABAPENTIN, CEFIXIME (FLEXERIL [CEFIXIME]), DICYCLOMINE HCL and ESTRADIOL (ESTROGEN) for an unknown indication. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN (Just sore initially). On 14-Jan-2021, the patient experienced VACCINATION COMPLICATION (Felt just like when she had COVID), PYREXIA (104.8 fever), CHILLS (Chills), HEADACHE (Bad headache) and NAUSEA (A lot of nausea). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency. In January 2021, PAIN (Just sore initially), VACCINATION COMPLICATION (Felt just like when she had COVID), PYREXIA (104.8 fever), CHILLS (Chills), HEADACHE (Bad headache) and NAUSEA (A lot of nausea) had resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 104.8 (High) 104.8. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Company comment Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. This case was linked to MOD-2021-239284, MOD-2021-239284 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Follow-up received and event duration and outcome updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: GABAPENTIN; FLEXERIL [CEFIXIME]; DICYCLOMINE HCL; ESTROGEN

Current Illness: Drug allergy (Morphine, codeine, hydrocodone, butran, dermabond, IV iron sucrose and iron dextran)

ID: 1542527
Sex: F
Age: 41
State: TX

Vax Date: 01/14/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Previously administered products included for an unreported indication: FLU VACCINE VII (sore arm.). On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Treatment for event included acetylsalicylic acid.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542528
Sex: F
Age:
State: GA

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Warm to touch for all of them; Injection site startedto feel itchy; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Warm to touch for all of them) and VACCINATION SITE PRURITUS (Injection site startedto feel itchy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Warm to touch for all of them) and VACCINATION SITE PRURITUS (Injection site startedto feel itchy). At the time of the report, VACCINATION SITE WARMTH (Warm to touch for all of them) and VACCINATION SITE PRURITUS (Injection site startedto feel itchy) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-003892, MOD-2021-004767, MOD-2021-008393 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event,s a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542529
Sex: M
Age: 81
State: TX

Vax Date: 01/06/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling; Itching; Erythema; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE ERYTHEMA (Erythema), VACCINATION SITE SWELLING (Swelling) and PRURITUS (Itching) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Erythema) and PRURITUS (Itching). On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE ERYTHEMA (Erythema), VACCINATION SITE SWELLING (Swelling) and PRURITUS (Itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: Follow-up received on 13-Apr-2021 included no new information.

Other Meds:

Current Illness:

ID: 1542530
Sex: F
Age: 22
State: LA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Exposure during pregnancy; Sore at the injection site; Headache; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Exposure during pregnancy), INJECTION SITE PAIN (Sore at the injection site) and HEADACHE (Headache) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 01-Jun-2021. On 14-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Exposure during pregnancy), INJECTION SITE PAIN (Sore at the injection site) and HEADACHE (Headache). The delivery occurred on an unknown date, which was reported as Outcome Pending. For foetus 1, The outcome was reported as Unknown. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 14-Jan-2021, EXPOSURE DURING PREGNANCY (Exposure during pregnancy) outcome was unknown. At the time of the report, INJECTION SITE PAIN (Sore at the injection site) and HEADACHE (Headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 24 Aug 2020 the patient received a positive pregnancy test. The patient estimated due date of 06 Jan 2021. There have been no complications or acute illnesses during this pregnancy. Pregnancy ultrasound taken but results have not been provided.Treatment information included Tylenol and Rhogam shot for being blood group O negative. Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1542531
Sex: F
Age: 30
State: TX

Vax Date: 01/25/2021
Onset Date: 06/21/2020
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of PREGNANCY (Pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination. The patient's past medical history included Alcohol use (1glass/week) on 16-Jun-2020. Concomitant products included METFORMIN for Polycystic ovarian syndrome, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for Pregnancy, LEVOTHYROXINE SODIUM (UNITHROID) from 01-Jul-2020 to an unknown date for Thyroid disorder. On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 21-May-2020 and the estimated date of delivery was 26-Feb-2021. On 21-Jun-2020, the patient experienced PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-fifth week of the pregnancy. At the time of the report, PREGNANCY (Pregnant) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jun-2020, Amniocentesis normal: normal. On 21-Jun-2020, Gestational diabetes: normal. On 21-Jun-2020, Glucose tolerance test: normal. On 21-Jun-2020, Pregnancy test: Positive. On 21-Jun-2020, Ultrasound scan normal: normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: METFORMIN; UNITHROID; PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS

Current Illness:

ID: 1542532
Sex: F
Age: 55
State: NY

Vax Date: 01/06/2021
Onset Date: 01/07/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm hurt; Injection site started itching; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PAIN (Arm hurt) and VACCINATION SITE PRURITUS (Injection site started itching) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced VACCINATION SITE PAIN (Arm hurt) and VACCINATION SITE PRURITUS (Injection site started itching). At the time of the report, VACCINATION SITE PAIN (Arm hurt) and VACCINATION SITE PRURITUS (Injection site started itching) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542533
Sex: F
Age:
State: NC

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (Discomfort) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 13-Jan-2021, the patient experienced DISCOMFORT (Discomfort). At the time of the report, DISCOMFORT (Discomfort) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided by the reporter. Treatment information was not provided. This case was linked to MOD-2021-007843 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542534
Sex: F
Age:
State: NY

Vax Date: 01/18/2021
Onset Date: 01/18/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching at the injection site; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced Itching at the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On 18 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: O25620A) for prophylaxis of COVID-19 infection. On 18 Jan 2021, the patient experienced Itching at the injection site. The patient was treated with Tranquilizer. Action taken with mRNA-1273 in response to the event was not reported. At the time of this report, the outcome of the event was unknown.; Reporter's Comments: This case concerns a female patient of unknown age, who experienced a non-serious expected event of Injection site pruritus on the same day after receiving their first of two planned doses of mRNA-1273 (Lot #O25620A). Treatment included Tranquilizer. Based on the current available information and temporal association between the use of the product and the onset of the event, a causal relationship cannot be excluded and the event is considered possibly related to the vaccine.

Other Meds:

Current Illness:

ID: 1542535
Sex: F
Age: 24
State: OH

Vax Date: 01/07/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Circular red rash around the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE RASH (Circular red rash around the vaccine) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced INJECTION SITE RASH (Circular red rash around the vaccine). At the time of the report, INJECTION SITE RASH (Circular red rash around the vaccine) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542536
Sex: F
Age: 39
State: MA

Vax Date: 01/07/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Injection site warmth) and VACCINATION SITE REACTION (vaccination site reaction) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced INJECTION SITE WARMTH (Injection site warmth). 14-Jan-2021, the patient experienced VACCINATION SITE REACTION (vaccination site reaction). At the time of the report, INJECTION SITE WARMTH (Injection site warmth) and VACCINATION SITE REACTION (vaccination site reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1542537
Sex: F
Age: 77
State: TX

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: face is red flushed; Today (16 Jan 2021) her arm is again red, itchy; Today (16 Jan 2021) her arm is again red, itchy; area of injection site is 4 inch long and 2 inch wide; injection site swelling; arm reaction like redness and swelling but it resolve.; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (face is red flushed), INJECTION SITE PRURITUS (Today (16 Jan 2021) her arm is again red, itchy), INJECTION SITE ERYTHEMA (arm reaction like redness and swelling but it resolve.), INJECTION SITE ERYTHEMA (Today (16 Jan 2021) her arm is again red, itchy) and INJECTION SITE SWELLING (area of injection site is 4 inch long and 2 inch wide) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included No adverse event (No medical history reported.). On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (arm reaction like redness and swelling but it resolve.) and INJECTION SITE SWELLING (injection site swelling). On 16-Jan-2021, the patient experienced FLUSHING (face is red flushed), INJECTION SITE PRURITUS (Today (16 Jan 2021) her arm is again red, itchy), INJECTION SITE ERYTHEMA (Today (16 Jan 2021) her arm is again red, itchy) and INJECTION SITE SWELLING (area of injection site is 4 inch long and 2 inch wide). In January 2021, INJECTION SITE SWELLING (injection site swelling) had resolved. At the time of the report, FLUSHING (face is red flushed), INJECTION SITE PRURITUS (Today (16 Jan 2021) her arm is again red, itchy), INJECTION SITE ERYTHEMA (Today (16 Jan 2021) her arm is again red, itchy) and INJECTION SITE SWELLING (area of injection site is 4 inch long and 2 inch wide) outcome was unknown and INJECTION SITE ERYTHEMA (arm reaction like redness and swelling but it resolve.) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1542538
Sex: F
Age: 30
State: TX

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: pregnant woman received Moderna COVID vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant woman received Moderna COVID vaccine) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. The patient's past medical history included Miscarriage (Spontaneous Abortion) on 20-Feb-2020 and Alcohol use (wine/alcohol occasionally). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 02-May-2020 and the estimated date of delivery was 06-Feb-2021. On 23-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnant woman received Moderna COVID vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the thirty-eighth week of the pregnancy. On 23-Jan-2021, EXPOSURE DURING PREGNANCY (pregnant woman received Moderna COVID vaccine) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-May-2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood test: normal (normal) normal. On an unknown date, Ultrasound scan: normal (normal) normal. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. On 14-Sep-2018, patient had a previous pregnancy that ended in live, full-term birth. On 20-Feb-2020, patient had a previous pregnancy that ended in miscarriage. Estimated date of conception was reported as 16-May-2020. The patient had established prenatal care. It was reported that there was no maternal history of subfertility, complications or acute illness during that pregnancy to date. The patient passed glucose tolerance test.; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 30-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds: PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness:

ID: 1542539
Sex: M
Age:
State: TX

Vax Date: 03/09/2021
Onset Date: 03/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Spots started to be itchy and now they are spreading to the wrists; Patient started seeing red spots on his both hands; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Patient started seeing red spots on his both hands) and PRURITUS (Spots started to be itchy and now they are spreading to the wrists) in a 54-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination. The patient's medical history information was not provided. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) and LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN-D) for an unknown indication. On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 ml. On 13-Mar-2021, the patient experienced RASH MACULAR (Patient started seeing red spots on his both hands). On 16-Mar-2021, the patient experienced PRURITUS (Spots started to be itchy and now they are spreading to the wrists). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, RASH MACULAR (Patient started seeing red spots on his both hands) and PRURITUS (Spots started to be itchy and now they are spreading to the wrists) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; CLARITIN-D

Current Illness:

ID: 1542540
Sex: F
Age: 61
State: IL

Vax Date: 01/04/2021
Onset Date: 01/01/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red circle that was warm; Red circle that was warm; Little itchy on upper (right) arm by the shoulder; Arm was sore; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE WARMTH (Red circle that was warm), VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder), VACCINATION SITE PAIN (Arm was sore) and VACCINATION SITE ERYTHEMA (Red circle that was warm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. No medical history was provided by the reporter. On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder). On 14-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Red circle that was warm) and VACCINATION SITE ERYTHEMA (Red circle that was warm). In January 2021, the patient experienced VACCINATION SITE PAIN (Arm was sore). The patient was treated with HYDROCORTISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. On 15-Jan-2021, VACCINATION SITE PRURITUS (Little itchy on upper (right) arm by the shoulder) had resolved, VACCINATION SITE PAIN (Arm was sore) had resolved. At the time of the report, VACCINATION SITE WARMTH (Red circle that was warm) and VACCINATION SITE ERYTHEMA (Red circle that was warm) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment also included ice.; Sender's Comments: This case concerns a 61 Y/O F with nonserious events of unexpected vaccination site warmth, and expected vaccination site pruritus, vaccination site erythema, and vaccination site pain. Event onset on Day 11 after first dose mRNA-1273. Treated with ibuprofen and hydrocortisone cream. Events resolved or resolving. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542541
Sex: M
Age: 50
State: TN

Vax Date: 12/23/2020
Onset Date: 12/25/2020
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by an other health care professional and describes the occurrence of INFLUENZA (Flu), COVID-19 (Tested positive for COVID), FEELING ABNORMAL ( feeling bad), MALAISE (feeling sick) and CHILLS (Started having chills) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included INFLIXIMAB (REMICADE), LOPERAMIDE HYDROCHLORIDE (IMODIUM) and ACYCLOVIR [ACICLOVIR] for an unknown indication. On 23-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Dec-2020, the patient experienced INFLUENZA (Flu) and MALAISE (feeling sick). On 26-Dec-2020, the patient experienced FEELING ABNORMAL ( feeling bad) and CHILLS (Started having chills). On 29-Dec-2020, the patient experienced COVID-19 (Tested positive for COVID). At the time of the report, INFLUENZA (Flu), COVID-19 (Tested positive for COVID), FEELING ABNORMAL ( feeling bad), MALAISE (feeling sick) and CHILLS (Started having chills) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, COVID-19: positive Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.; Sender's Comments: Based on biological implausibility the event of COVID-19 infection is assessed as unlikely related to mRNA-1273. Based on the current available information and temporal association between the use of the product and the start date of the events of flu like, chills, general malaise, a causal relationship cannot be excluded."

Other Meds: REMICADE; IMODIUM; ACYCLOVIR [ACICLOVIR]

Current Illness:

ID: 1542542
Sex: F
Age:
State:

Vax Date: 01/23/2021
Onset Date: 01/23/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: severe hip pain on her left joint side; cannot move her leg a lot; cannot walk; muscle pain; fever; chills; headache; abdominal pain; nausea; This spontaneous case was reported by a physician and describes the occurrence of MUSCULOSKELETAL DISCOMFORT (severe hip pain on her left joint side), LIMB DISCOMFORT (cannot move her leg a lot), GAIT DISTURBANCE (cannot walk), MYALGIA (muscle pain) and PYREXIA (fever) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History was provided by the reporter. On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced MUSCULOSKELETAL DISCOMFORT (severe hip pain on her left joint side), LIMB DISCOMFORT (cannot move her leg a lot), GAIT DISTURBANCE (cannot walk), MYALGIA (muscle pain), PYREXIA (fever), CHILLS (chills), HEADACHE (headache), ABDOMINAL PAIN (abdominal pain) and NAUSEA (nausea). The patient was treated with TRAMADOL for Adverse event, at an unspecified dose and frequency; ONDANSETRON (ZOFRAN [ONDANSETRON]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN SODIUM (IBUPROFEN [IBUPROFEN SODIUM]) (oral) for Adverse event, at a dose of 600 milligram. At the time of the report, MUSCULOSKELETAL DISCOMFORT (severe hip pain on her left joint side), LIMB DISCOMFORT (cannot move her leg a lot), GAIT DISTURBANCE (cannot walk), MYALGIA (muscle pain), PYREXIA (fever), CHILLS (chills), HEADACHE (headache), ABDOMINAL PAIN (abdominal pain) and NAUSEA (nausea) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Body temperature: 103 (High) Patient had fever of 103. On 04-Jun-2021, SARS-CoV-2 test positive: positive (Positive) Patient was sick/symptomatic for 11 days due to COVID-19. On an unknown date, Blood culture: pending Inconclusive. On an unknown date, Blood test: pending Inconclusive. On an unknown date, X-ray: pending Inconclusive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitants were not provided. Patient's treatment plan included 2 Liters of IV fluids.

Other Meds:

Current Illness:

ID: 1542543
Sex: U
Age:
State: NH

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cellulitis reaction at the injection site was warm, firm, red, and getting bigger; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE CELLULITIS (Cellulitis reaction at the injection site was warm, firm, red, and getting bigger) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE CELLULITIS (Cellulitis reaction at the injection site was warm, firm, red, and getting bigger). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site cellulitis, at a dose of UNK dosage form; IBUPROFEN for Vaccination site cellulitis, at a dose of UNK dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Vaccination site cellulitis, at a dose of UNK dosage form. At the time of the report, VACCINATION SITE CELLULITIS (Cellulitis reaction at the injection site was warm, firm, red, and getting bigger) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. The cellulitis was is warm, firm, red, and getting bigger despite taking Tylenol, ibuprofen, and Benadryl.; Sender's Comments: This case concerns a patient of unknown age and gender with nonserious unexpected vaccination site cellulitis. Event onset with unknown latency after first dose mRNA-1273. Treatment with paracetamol, ibuprofen and diphenhydramine. Events ongoing. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542544
Sex: F
Age: 49
State: WV

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cheeks really red; Redness at the injection site; Chills in the middle of the night; Fever of 103; This spontaneous case was reported by a consumer and describes the occurrence of FLUSHING (Cheeks really red), VACCINATION SITE ERYTHEMA (Redness at the injection site), CHILLS (Chills in the middle of the night) and PYREXIA (Fever of 103) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced FLUSHING (Cheeks really red), VACCINATION SITE ERYTHEMA (Redness at the injection site), CHILLS (Chills in the middle of the night) and PYREXIA (Fever of 103). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FLUSHING (Cheeks really red), VACCINATION SITE ERYTHEMA (Redness at the injection site), CHILLS (Chills in the middle of the night) and PYREXIA (Fever of 103) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jan-2021, Body temperature: 103 (High) 103. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542545
Sex: M
Age: 50
State: OH

Vax Date: 01/05/2021
Onset Date: 01/05/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Body aches, not constant but on and off; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (Body aches, not constant but on and off) and FATIGUE (Fatigue) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (COVID-19 Infection) on 30-Dec-2020. Concomitant products included METOPROLOL, SIMVASTATIN and FLUOXETINE HYDROCHLORIDE (PROZAC) for an unknown indication. On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jan-2021, the patient experienced PAIN (Body aches, not constant but on and off) and FATIGUE (Fatigue). At the time of the report, PAIN (Body aches, not constant but on and off) and FATIGUE (Fatigue) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment details were provided Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow up received and contain significant information: changed events outcome from unknown to recovering.

Other Meds: METOPROLOL; SIMVASTATIN; PROZAC

Current Illness:

ID: 1542546
Sex: F
Age: 67
State: NJ

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Vaccination site bruising; Anxiety; Ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (Vaccination site bruising), ANXIETY (Anxiety) and PAIN (Ache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included ERGOCALCIFEROL, RETINOL PALMITATE (VITAMINS A & D), METOPROLOL, OXYBUTYNIN, TELMISARTAN, OMEPRAZOLE and CENTRUM SILVER +50 for an unknown indication. On 13-Jan-2021 at 2:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ANXIETY (Anxiety) and PAIN (Ache). On 13-Jan-2021 at 2:30 PM, the patient experienced VACCINATION SITE BRUISING (Vaccination site bruising). At the time of the report, VACCINATION SITE BRUISING (Vaccination site bruising), ANXIETY (Anxiety) and PAIN (Ache) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: VITAMINS A & D; METOPROLOL; OXYBUTYNIN; TELMISARTAN; OMEPRAZOLE; CENTRUM SILVER +50

Current Illness:

ID: 1542547
Sex: F
Age:
State: NC

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: burning sensation; metallic taste; Hot flashes; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (burning sensation ), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037k20a) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced BURNING SENSATION (burning sensation ) and DYSGEUSIA (metallic taste). On an unknown date, the patient experienced HOT FLUSH (Hot flashes). At the time of the report, BURNING SENSATION (burning sensation ), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) outcome was unknown. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1542548
Sex: M
Age: 37
State: CA

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain on arm; Dizziness/feel light headed; Tingling on face; Tingling on lips; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips), PAIN IN EXTREMITY (Pain on arm) and DIZZINESS (Dizziness/feel light headed) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011220a) for COVID-19 vaccination. No Medical History information was reported. On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips) and DIZZINESS (Dizziness/feel light headed). On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain on arm). At the time of the report, PARAESTHESIA (Tingling on face), PARAESTHESIA ORAL (Tingling on lips), PAIN IN EXTREMITY (Pain on arm) and DIZZINESS (Dizziness/feel light headed) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542549
Sex: M
Age: 73
State: TX

Vax Date: 12/30/2020
Onset Date: 01/04/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Could not sleep; Left arm to wrist swollen; Left arm to wrist had incredibly bad itchy feeling; Left arm to wrist turned red; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Could not sleep), VACCINATION SITE SWELLING (Left arm to wrist swollen), VACCINATION SITE PRURITUS (Left arm to wrist had incredibly bad itchy feeling) and VACCINATION SITE ERYTHEMA (Left arm to wrist turned red) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K204(4 or A)) for COVID-19 vaccination. The patient's past medical history included High cholesterol since an unknown date and Retinal tear (in both eyes.). Concurrent medical conditions included Seasonal allergy, Egg allergy and Herbal allergy. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2021, the patient experienced INSOMNIA (Could not sleep), VACCINATION SITE SWELLING (Left arm to wrist swollen), VACCINATION SITE PRURITUS (Left arm to wrist had incredibly bad itchy feeling) and VACCINATION SITE ERYTHEMA (Left arm to wrist turned red). At the time of the report, INSOMNIA (Could not sleep), VACCINATION SITE SWELLING (Left arm to wrist swollen), VACCINATION SITE PRURITUS (Left arm to wrist had incredibly bad itchy feeling) and VACCINATION SITE ERYTHEMA (Left arm to wrist turned red) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events a causal relationship cannot be excluded

Other Meds: BABY ASPIRIN

Current Illness: Egg allergy; Herbal allergy; High cholesterol; Seasonal allergy

ID: 1542550
Sex: F
Age: 70
State: TX

Vax Date: 01/12/2021
Onset Date: 01/01/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. Concomitant products included LOSARTAN, ATORVASTATIN, LEVOTHYROXINE SODIUM (SYNTHROID), METOPROLOL and ACETYLSALICYLIC ACID (ASPIRIN) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced VACCINATION SITE PAIN (Sore arm). At the time of the report, VACCINATION SITE PAIN (Sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event, a causal relationship cannot be excluded.

Other Meds: LOSARTAN; ATORVASTATIN; SYNTHROID; METOPROLOL; ASPIRIN

Current Illness:

ID: 1542551
Sex: F
Age:
State: CA

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hypertensive; felt dazed out; did not feel to answer/talk; Tachycardia; palpations; Fatigue; Headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (Hypertensive), FATIGUE (Fatigue), HEADACHE (Headache), FEELING ABNORMAL (felt dazed out; did not feel to answer/talk) and TACHYCARDIA (Tachycardia; palpations) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for an unknown indication. It was reported that the patient took no medication and had no allergies. On 29-Dec-2020, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced HYPERTENSION (Hypertensive), FATIGUE (Fatigue), HEADACHE (Headache), FEELING ABNORMAL (felt dazed out; did not feel to answer/talk) and TACHYCARDIA (Tachycardia; palpations). At the time of the report, HYPERTENSION (Hypertensive), FATIGUE (Fatigue), HEADACHE (Headache), FEELING ABNORMAL (felt dazed out; did not feel to answer/talk) and TACHYCARDIA (Tachycardia; palpations) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Dec-2020, Blood pressure systolic: 176 (High) 176, 160 (High) 160, 150 (High) 150 and 130 (High) gradually lowered to 130. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication was not reported. Treatment medication was not reported.

Other Meds:

Current Illness:

ID: 1542552
Sex: F
Age: 43
State: TN

Vax Date: 01/16/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching; Bulls eye rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching) and RASH (Bulls eye rash) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination. Concurrent medical conditions included Bursitis. Concomitant products included MELOXICAM for an unknown indication. On 16-Jan-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced PRURITUS (Itching). 16-Jan-2021, the patient experienced RASH (Bulls eye rash). At the time of the report, PRURITUS (Itching) and RASH (Bulls eye rash) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds: MELOXICAM

Current Illness: Bursitis

ID: 1542553
Sex: F
Age: 85
State: AL

Vax Date: 01/22/2021
Onset Date: 01/01/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Shortness of Breath; A spontaneous report was received from a consumer, concerning herself, an 85-year-old female patient, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced shortness of breath. The patient's medical history was not provided. The patient had no concomitant medications. On 22-Jan-2021 at 02:00PM, prior to the onset of event, the patient received the first of two planned doses of mRNA-1273 (lot number unknown) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On an unspecified date in Jan-2021, 1 week after the first shot of the Moderna vaccine the patient experienced shortness of breath. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of event shortness of breath was not provided.; Reporter's Comments: This spontaneous report concerns an 85-year-old female patient who experienced the event of shortness of breath 1 week after the administration of the first dose of the mRNA-1273 vaccine (Lot #: unknown, expiration date-unknown). No treatment was reported, and outcome is unknown. There is not enough information of assess the causal association between he reported event and the administration of mRNA-1273 vaccine. Patient is of an advanced age and critical details regarding the patient's medical history is lacking. Main field defaults to ?possibly related'

Other Meds:

Current Illness:

ID: 1542554
Sex: M
Age: 61
State: WA

Vax Date: 01/13/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Positive covid test; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (Positive covid test) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported.). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (Positive covid test). At the time of the report, SARS-COV-2 TEST POSITIVE (Positive covid test) had not resolved. Not Provided DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test: negative (Negative) Negative. On 15-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications reported by investigator o No treatment medications provided by the reporter.; Sender's Comments: Based on the current available information, the mRNA-1273 does not contain a virus capable of causing infection and with the occurrence of Covid-19 test positive after vaccination, this event is assessed as unlikely related to mRNA-1273.

Other Meds:

Current Illness:

ID: 1542555
Sex: F
Age: 66
State: FL

Vax Date: 01/07/2021
Onset Date: 01/09/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 3 inch redness on the injection site; Rash on injection site; Swelling on the injection site looks like half a baseball size/bumpy injection site; Hard on injection site; Injection area is firm/ Painful to touch; Hot on the injection site; Itching on the injection area; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot on the injection site), VACCINATION SITE PRURITUS (Itching on the injection area), VACCINATION SITE ERYTHEMA (3 inch redness on the injection site), VACCINATION SITE RASH (Rash on injection site) and VACCINATION SITE SWELLING (Swelling on the injection site looks like half a baseball size/bumpy injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Palpitation. Concomitant products included METOPROLOL for Palpitation. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching on the injection area). On 13-Jan-2021, the patient experienced VACCINATION SITE WARMTH (Hot on the injection site), VACCINATION SITE ERYTHEMA (3 inch redness on the injection site), VACCINATION SITE RASH (Rash on injection site), VACCINATION SITE SWELLING (Swelling on the injection site looks like half a baseball size/bumpy injection site), VACCINATION SITE INDURATION (Hard on injection site) and VACCINATION SITE PAIN (Injection area is firm/ Painful to touch). On 15-Jan-2021, VACCINATION SITE SWELLING (Swelling on the injection site looks like half a baseball size/bumpy injection site) and VACCINATION SITE INDURATION (Hard on injection site) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot on the injection site), VACCINATION SITE ERYTHEMA (3 inch redness on the injection site) and VACCINATION SITE PAIN (Injection area is firm/ Painful to touch) outcome was unknown and VACCINATION SITE PRURITUS (Itching on the injection area) and VACCINATION SITE RASH (Rash on injection site) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: METOPROLOL

Current Illness: Palpitation

ID: 1542556
Sex: F
Age: 73
State: OK

Vax Date: 01/07/2021
Onset Date: 01/08/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itching really bad at injection site; Very red at injection site (3 by 2"); Hard at injection site; Very hot at injection site; Rash in wrist area of same arm of injection; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash in wrist area of same arm of injection), VACCINATION SITE PRURITUS (Itching really bad at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site (3 by 2")), VACCINATION SITE INDURATION (Hard at injection site) and VACCINATION SITE WARMTH (Very hot at injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced RASH (Rash in wrist area of same arm of injection). On 15-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itching really bad at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site (3 by 2")), VACCINATION SITE INDURATION (Hard at injection site) and VACCINATION SITE WARMTH (Very hot at injection site). On 09-Jan-2021, RASH (Rash in wrist area of same arm of injection) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Itching really bad at injection site), VACCINATION SITE ERYTHEMA (Very red at injection site (3 by 2")), VACCINATION SITE INDURATION (Hard at injection site) and VACCINATION SITE WARMTH (Very hot at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment and concomitant medications were not provided by reporter.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542557
Sex: F
Age:
State: NC

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hot flashes; Burning sensation; metallic taste; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced BURNING SENSATION (Burning sensation) and DYSGEUSIA (metallic taste). On an unknown date, the patient experienced HOT FLUSH (Hot flashes). At the time of the report, BURNING SENSATION (Burning sensation), DYSGEUSIA (metallic taste) and HOT FLUSH (Hot flashes) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1542558
Sex: F
Age:
State:

Vax Date: 01/06/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Red spot the size of half dollar around where injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Red spot the size of half dollar around where injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 06-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Red spot the size of half dollar around where injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Red spot the size of half dollar around where injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542559
Sex: F
Age: 70
State: GA

Vax Date: 01/07/2021
Onset Date: 01/07/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: a round spot in the injection site area; injection site itchiness, redness; right side neck pain, side of the face; pain on the side of her face; soreness on her shoulder; headache; Pain in right upper back; Ringing ear; Feels stocked up on her ears; Vaccination site pruritus; redness and soreness; redness and soreness; This spontaneous case was reported by a consumer and describes the occurrence of EAR INFECTION (Feels stocked up on her ears), NECK PAIN (right side neck pain, side of the face), FACIAL PAIN (pain on the side of her face), INJECTION SITE DISCOLOURATION (a round spot in the injection site area) and TINNITUS (Ringing ear) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Co-suspect product included non-company product CETIRIZINE HYDROCHLORIDE (CETRIZINE) for an unknown indication. The patient's past medical history included Surgery (Shoulder surgery) in 2021. Concurrent medical conditions included Tetanus, Allergy to antibiotic (Bactrim-hives), Sulfonamide allergy (Sulphur drugs.), Iodine allergy, Mitral valve disease NOS (Leaky mitral valve) since November 2012, Polyp NOS (polyp on esophagus) since 1994, Polycystic ovarian syndrome since 1975, Acid reflux (esophageal) since 2014, Idiopathic peripheral autonomic neuropathy (Idiopathic peripheral neuropathy in both feet) since August 2019, Peripheral neuropathic pain (Chronic neuropathic pain in back and right leg) since August 2019 and Degenerative disc disease (Disc degenerative in back and neck) since 2001. Concomitant products included MELATONIN for Acid reflux (esophageal), CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for Allergy, ATORVASTATIN CALCIUM (LIPITOR) from 10-Oct-2020 to an unknown date for Cholesterol, MACROGOL 3350 (MIRALAX) for Constipation, ESTRADIOL (YUVAFEM) for Hormone replacement therapy, METOPROLOL SUCCINATE, IRBESARTAN, AMLODIPINE and AMLODIPINE BESILATE (NORVASC) for Hypertension, DICLOFENAC SODIUM for Pain, GABAPENTIN for Peripheral neuropathy, LEVOTHYROXINE for Thyroid disorder, VITAMIN D3, VITAMIN B12 NOS (VITAMIN B 12 [VITAMIN B12 NOS]), ACETYLSALICYLIC ACID (BABY ASPIRIN) from 12-Apr-2020 to an unknown date and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication. On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose and CETIRIZINE HYDROCHLORIDE (CETRIZINE) (unknown route) 10 mg once a day. On 07-Jan-2021, the patient experienced EAR INFECTION (Feels stocked up on her ears), VACCINATION SITE PRURITUS (Vaccination site pruritus), INJECTION SITE ERYTHEMA (redness and soreness) and INJECTION SITE PAIN (redness and soreness). On 11-Jan-2021, the patient experienced TINNITUS (Ringing ear). On 12-Jan-2021, the patient experienced BACK PAIN (Pain in right upper back). On 13-Jan-2021, the patient experienced NECK PAIN (right side neck pain, side of the face), FACIAL PAIN (pain on the side of her face), HEADACHE (headache) and ARTHRALGIA (soreness on her shoulder). On 15-Jan-2021, the patient experienced INJECTION SITE DISCOLOURATION (a round spot in the injection site area) and INJECTION SITE PRURITUS (injection site itchiness, redness). On 08-Jan-2021, EAR INFECTION (Feels stocked up on her ears), VACCINATION SITE PRURITUS (Vaccination site pruritus) and INJECTION SITE PAIN (redness and soreness) had resolved. On 14-Jan-2021, NECK PAIN (right side neck pain, side of the face), FACIAL PAIN (pain on the side of her face), HEADACHE (headache) and ARTHRALGIA (soreness on her shoulder) had resolved. At the time of the report, INJECTION SITE DISCOLOURATION (a round spot in the injection site area), TINNITUS (Ringing ear), BACK PAIN (Pain in right upper back), INJECTION SITE PRURITUS (injection site itchiness, redness) and INJECTION SITE ERYTHEMA (redness and soreness) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2012, Echocardiogram: unknown (Inconclusive) Mild. In August 2019, Electromyogram: unknown (Inconclusive) Idiopathic peripheral neuropathy Chronic neuropathic pain in back and right leg. On 03-Nov-2019, Endoscopy: unknown (Inconclusive) Checked periodically by gastroenterologist, Doctor said common.. On 27-Jan-2021, Laparoscopy: unknown (Inconclusive) PCOS diagnosed via laparoscopy. On 27-Jan-2021, SARS-CoV-2 test: negative (Negative) negative. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. Treatment: Used a heating pad Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up received on 7-6-2021. Patient demographics added, medical history added, lab data added, concomitant medication added, event added

Other Meds: LEVOTHYROXINE; METOPROLOL SUCCINATE; IRBESARTAN; AMLODIPINE; YUVAFEM; VITAMIN D3; VITAMIN B 12 [VITAMIN B12 NOS]; MELATONIN; MIRALAX; BABY ASPIRIN; LIPITOR; GABAPENTIN; ZYRTEC ALLERGY; NORVASC; ASPIRIN (E.C.); DICLOFENAC SODIUM

Current Illness: Acid reflux (esophageal); Allergy to antibiotic (Bactrim-hives); Degenerative disc disease (Disc degenerative in back and neck); Idiopathic peripheral autonomic neuropathy (Idiopathic peripheral neuropathy in both feet); Iodine allergy; Mitral valve disease NOS (Leaky mitral valve); Peripheral neuropathic pain (Chronic neuropathic pain in back and right leg); Polycystic ovarian syndrome; Polyp NOS (polyp on esophagus); Sulfonamide allergy (Sulphur drugs.); Tetanus

ID: 1542560
Sex: M
Age:
State:

Vax Date:
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Having hard time breathing; Hardly slept; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Having hard time breathing) and INSOMNIA (Hardly slept) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced DYSPNOEA (Having hard time breathing) and INSOMNIA (Hardly slept). At the time of the report, DYSPNOEA (Having hard time breathing) and INSOMNIA (Hardly slept) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications were reported. No treatment related information has been reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542561
Sex: U
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Flashing light reaction; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPSIA (Flashing light reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PHOTOPSIA (Flashing light reaction). At the time of the report, PHOTOPSIA (Flashing light reaction) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1542562
Sex: F
Age: 58
State: CA

Vax Date: 01/07/2021
Onset Date: 01/12/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling around her eyes, lips, and cheeks; Swelling around her eyes, lips, and cheeks; Swelling at the injection site; Itchiness at the injection site; Facial swelling; Rash developed around the injection site; A spontaneous report was received from a healthcare professional, concerning a 58-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced facial swelling, rash developed around the injection site, swelling around her eyes, lips, and cheeks, swelling at the injection site and itchiness at the injection site. The patient's medical history was not provided. No relevant concomitant medications were reported. On 07 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On 12 Jan 2021, the patient experienced facial swelling and rash developed around the injection site. On an unknown date, the patient experienced swelling around her eyes, lips, and cheeks, swelling at the injection site and itchiness at the injection site. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not reported. At the time of this report, the outcome of the event facial swelling was resolved and the outcome of events rash developed around the injection site, swelling around her eyes, lips, and cheeks, swelling at the injection site and itchiness at the injection site were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542563
Sex: F
Age: 70
State: FL

Vax Date: 01/06/2021
Onset Date: 01/06/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Got really sick after; Aches and pains; severe chills; fever around 100.05 f; Terrible headache; Extreme fatigue; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Got really sick after), PAIN (Aches and pains), CHILLS (severe chills), PYREXIA (fever around 100.05 f) and HEADACHE (Terrible headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Thyroid disorder, High cholesterol and Seizure. On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION COMPLICATION (Got really sick after), PAIN (Aches and pains), CHILLS (severe chills), PYREXIA (fever around 100.05 f), HEADACHE (Terrible headache) and FATIGUE (Extreme fatigue). On 09-Jan-2021, PYREXIA (fever around 100.05 f) had resolved. At the time of the report, VACCINATION COMPLICATION (Got really sick after), PAIN (Aches and pains), CHILLS (severe chills), HEADACHE (Terrible headache) and FATIGUE (Extreme fatigue) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jan-2021, Body temperature: 100.05 100.05 degree F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.

Other Meds:

Current Illness:

ID: 1542564
Sex: F
Age: 43
State: FL

Vax Date: 01/12/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: COVID-19 test is positive; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19 test is positive) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided). Concomitant products included ISOTRETINOIN and IBUPROFEN (ADVIL [IBUPROFEN]) for an unknown indication. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced COVID-19 (COVID-19 test is positive). At the time of the report, COVID-19 (COVID-19 test is positive) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.

Other Meds: ISOTRETINOIN; ADVIL [IBUPROFEN]

Current Illness:

ID: 1542565
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Scratchy throat; Injection site rash; This spontaneous case was reported by an other health care professional and describes the occurrence of THROAT IRRITATION (Scratchy throat) and VACCINATION SITE RASH (Injection site rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 07-Jan-2021 at 12:26 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE RASH (Injection site rash). On 14-Jan-2021 at 12:26 PM, the patient experienced THROAT IRRITATION (Scratchy throat). At the time of the report, THROAT IRRITATION (Scratchy throat) and VACCINATION SITE RASH (Injection site rash) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.

Other Meds:

Current Illness:

ID: 1542566
Sex: F
Age: 81
State: NY

Vax Date: 01/13/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Terrible pain under the arm at the fatty of the brest; Chills; Swollen; A little bit hurt; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (A little bit hurt), AXILLARY PAIN (Terrible pain under the arm at the fatty of the brest) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 1138) for COVID-19 vaccination. The patient's past medical history included No adverse event (No adverse event reported). On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PERIPHERAL SWELLING (Swollen) and PAIN IN EXTREMITY (A little bit hurt). On 15-Jan-2021, the patient experienced AXILLARY PAIN (Terrible pain under the arm at the fatty of the brest) and CHILLS (Chills). At the time of the report, PERIPHERAL SWELLING (Swollen), PAIN IN EXTREMITY (A little bit hurt), AXILLARY PAIN (Terrible pain under the arm at the fatty of the brest) and CHILLS (Chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1542567
Sex: F
Age: 75
State: MI

Vax Date: 01/12/2021
Onset Date: 01/14/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: tongue started to swell, it got red, it was burning; tongue started to swell, it got red, it was burning; tongue started to swell, it got red, it was burning; Canker sores; This spontaneous case was reported by a consumer and describes the occurrence of SWOLLEN TONGUE (tongue started to swell, it got red, it was burning), TONGUE ERYTHEMA (tongue started to swell, it got red, it was burning), TONGUE DISCOMFORT (tongue started to swell, it got red, it was burning) and APHTHOUS ULCER (Canker sores) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced SWOLLEN TONGUE (tongue started to swell, it got red, it was burning), TONGUE ERYTHEMA (tongue started to swell, it got red, it was burning), TONGUE DISCOMFORT (tongue started to swell, it got red, it was burning) and APHTHOUS ULCER (Canker sores). At the time of the report, SWOLLEN TONGUE (tongue started to swell, it got red, it was burning), TONGUE ERYTHEMA (tongue started to swell, it got red, it was burning), TONGUE DISCOMFORT (tongue started to swell, it got red, it was burning) and APHTHOUS ULCER (Canker sores) was resolving. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. The patient said she had these mixed nuts containing peanuts, walnuts and almonds from Christmas and ate some on Jan14. The patient thought this was weird as she never had a nut allergy and she didn't see this as one of the side effects from the Moderna COVID-19 vaccine. No concomitant medication details were provided. No treatment medication details were provided. Most recent FOLLOW-UP information incorporated above includes: On 13-Apr-2021: On 18-Jun-2021: Reporter contact information updated; Reporter's Comments: .; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542568
Sex: F
Age:
State: CA

Vax Date: 01/08/2021
Onset Date: 01/08/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hard lump on the injection site; hive on injection site; soreness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard lump on the injection site), VACCINATION SITE URTICARIA (hive on injection site) and INJECTION SITE PAIN (soreness) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction (no medical history reported). On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced INJECTION SITE PAIN (soreness). On 15-Jan-2021, the patient experienced VACCINATION SITE INDURATION (hard lump on the injection site) and VACCINATION SITE URTICARIA (hive on injection site). At the time of the report, VACCINATION SITE INDURATION (hard lump on the injection site) and VACCINATION SITE URTICARIA (hive on injection site) had not resolved and INJECTION SITE PAIN (soreness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were reported. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542569
Sex: F
Age: 33
State: TX

Vax Date: 01/12/2021
Onset Date: 01/13/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: injection site warm; injection site hard; injection site itchy; injection site swollen; big red welt; This spontaneous case was reported by a patient and describes the occurrence of INJECTION SITE WARMTH (injection site warm), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (big red welt) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The patient's past medical history included No adverse event. Concomitant products included ETHINYLESTRADIOL, ETONOGESTREL (NUVARING), METFORMIN, LISINOPRIL, GLIPIZIDE, SPIRONOLACTONE, DOXYCYCLINE and vitamin c. On 12-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 13-Jan-2021, the patient experienced INJECTION SITE WARMTH (injection site warm), VACCINATION SITE INDURATION (injection site hard), VACCINATION SITE PRURITUS (injection site itchy), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (big red welt). At the time of the report, INJECTION SITE WARMTH (injection site warm), VACCINATION SITE INDURATION (injection site hard) and VACCINATION SITE PRURITUS (injection site itchy) outcome was unknown and VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (big red welt) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment medication was reported.

Other Meds: NUVARING; METFORMIN; LISINOPRIL; GLIPIZIDE; SPIRONOLACTONE; DOXYCYCLINE; vitamin c

Current Illness:

ID: 1542570
Sex: F
Age:
State:

Vax Date: 01/13/2021
Onset Date:
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm hurts; body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurts), PAIN (body ache) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event. On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurts), PAIN (body ache) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm hurts), PAIN (body ache) and HEADACHE (headache) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Most recent FOLLOW-UP information incorporated above includes: On 29-Jan-2021: No specific follow-up information recorded.

Other Meds:

Current Illness:

ID: 1542571
Sex: F
Age:
State: FL

Vax Date: 01/08/2021
Onset Date: 01/16/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: broke out with a large reaction at the injection site; hot; itchy; swollen; red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (broke out with a large reaction at the injection site), VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history provided). On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE REACTION (broke out with a large reaction at the injection site), VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE REACTION (broke out with a large reaction at the injection site), VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (itchy), VACCINATION SITE SWELLING (swollen) and VACCINATION SITE ERYTHEMA (red) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitants or treatment medications were reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1542572
Sex: F
Age: 54
State: NC

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Very itchy; Fiery red; Pink most of the week; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (Pink most of the week), VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Fiery red) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination. The patient's past medical history included No adverse event (no historical condition was reported). On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Pink most of the week). On 12-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Fiery red). At the time of the report, VACCINATION SITE DISCOLOURATION (Pink most of the week) outcome was unknown and VACCINATION SITE PRURITUS (Very itchy) and VACCINATION SITE ERYTHEMA (Fiery red) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

ID: 1542573
Sex: F
Age: 69
State: TX

Vax Date: 01/15/2021
Onset Date: 01/15/2021
Rec V Date: 08/11/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever; Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain) and PYREXIA (Fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No medical history reported). On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm pain). On 16-Jan-2021, the patient experienced PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Arm pain) and PYREXIA (Fever) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 599,999

Page last modified: 03 October 2021 5:28pm